• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare

    5/29/24 10:51:20 AM ET
    $BMY
    $CVS
    $JNJ
    $KO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $BMY alert in real time by email

    The mass retirement of the boomer generation has been anticipated as one of the most impactful economic events of the 21st century.

    Economists are still trying to understand the consequences of the wealthiest generation in human history going into retirement by the millions each year.

    Expectations so far have been varied. While having massive amounts of people leave their productive jobs in exchange for government pensions has been deemed an existential risk for modern civilization, the situation also entails the largest wealth transfer in history, as baby boomers pass away and leave their wealth to their Gen-X and Millennial offspring.

    Are Boomers Preventing The Invisible Recession?

    The short term consequences of this transition on the U.S. economy are still being defined. Some experts anticipate that retiring baby boomers will boost the economy through increased spending in their golden years.

    That has been the dominant narrative for economists looking at spending patterns across age gaps. The average behavior for citizens of advanced economies has been commonly explained by using the "life-cycle hypothesis."

    This hypothesis argues that people try to maintain roughly the same level of consumption throughout their lifetimes. They do this by taking debt when their income is low in their youth, saving when their income is high during middle-age, and diving into their savings (or liquidating investments) in retirement.

    This hypothesis has led economists to believe that the transition of baby boomers into retirement could revitalize the economy. As retirees begin to liquidate billions of dollars in previously stored assets, such as stocks, properties, and other investments, this influx of active capital will be fed into the market to finance their later-life lifestyles.

    The argument is valid when considering that the baby boomer generation makes up 20% of the U.S. population, but owns 52% of its wealth, according to Fed data.

    Wall Street veteran Edward Yardeni recently wrote in the Financial Times that the boomer generation and its spending habits are saving the American economy from a recession.

    Following the pandemic and the outbreak of war in Europe, a U.S. recession was widely expected but never arrived, making it the "most widely anticipated recession that didn't happen."

    A poll conducted in May revealed that most Americans think they're living in a recession, although the numbers don't tell the same story.

    Over the past two years, it's been reasonable to expect a recession given the signals stemming from the U.S. economy. Decades-high inflation leading up to rising interest rates could have naturally resulted in contraction.

    Another sign of an upcoming recession, says Yardeni, was the inversion of the yield curve for the 2-year and 10-year Treasury notes, which has consistently been a predictive sign of contraction for the past seven recessions.

    Yet for Yardeni, the injection of potentially $76 trillion of boomer wealth into the economy has been the principal barricade holding off a recession in the U.S., as baby boomers spend their hard-earned cash in travel, leisure, gastronomy and healthcare.

    "All these services industries have been expanding their payrolls, thus boosting real incomes, and fuelling more spending," writes Yardeni.

    Read also: Ex-Teacher-Turned-Fund Manager’s Bold Bet On Rising Rates Propels Turned A Small Pension Fund Into A Top Performer — Here’s How

    Yet Boomers Are Not Burning Through Their Retirement Funds

    Other commentators have not been as quick to label boomer money as the savior of the story. 

    According to a piece in The Economist, the unprecedentedly rich boomer generation has also been extraordinarily stingy.

    According to the analysis, baby boomers have been preserving, or even trying to grow their capital more than any other generation going into retirement in the past.

    All across the developed world, the rates of saving versus spending for people above the age of 65 has increased. In the U.S. by the mid-1990s, "those aged between 65 and 74 spent 10% more than they took in, but since 2015 people this age have saved about 1% of their income," according to the outlet.

    Similar examples can be found in countries experiencing an early wave of boomer retirement, like Italy and Japan, which have two of the oldest populations on the planet. More examples across the UK, Canada, Australia, South Korea and Germany show that boomers are clinging to their investments and slowing down the rate of spending, going directly against traditional economic theory and expectations.

    The reasons for this behavior include a desire to leave part of their wealth to struggling younger generations, as well as worries about health-care access following the Covid-19 pandemic, which also changed consumer patterns permanently for the older folks.

    Boomer Spending Trends: Numbers point in the direction of a bigger desire to bequeath saved-up wealth to generations that are having trouble affording their first home or repaying student loans, with Americans inheriting "about 50% more each year than they did each year in the 1980s and 1990s."

    As the life expectancy for current retirees grows, so does their willingness to be prepared to face health-care costs through a longer time frame, thus becoming more cautious with their spending.

    Ownership of equities and real estate has never been higher in U.S. history.

    Data from the Federal Reserve of St. Louis shows that U.S. household net-worth hit its highest historical level during the latest available reading, from December 2023. The same goes for the holding of financial assets like stocks and bonds, as well as non-financial assets like real estate.

    This supports the notion that baby boomers entering retirement are not liquidating their assets as quickly as many economists had anticipated.

    In turn, retired boomers may be prioritizing passive income from rental properties as well as stock dividends.

    Investors looking to replicate this strategy in the stock market could be looking at reliable high-dividend stocks like Coca-Cola Co (NYSE:KO) and Verizon Communications Inc. (NYSE:VZ), which boasts a 12-month trailing dividend yield of 6.74%.

    Realty Income Corp (NYSE:O) or AT&T Inc (NYSE:T) are also on the list, both with a yield of over 5% this year and an annual growth rate of over 3%.

    Three health care stocks have had dividend yields above 4% this year, including Pfizer Inc (NYSE:PFE), CVS Health Corp (NYSE:CVS) and Bristol-Myers Squibb Co (NYSE:BMY). Johnson & Johnson (NYSE:JNJ) trails behind with a dividend yield of 3.2%.

    Now read: Early Retirement Pitfall: Man Faces Liquidity Crisis Despite $2.4M In 401(K)

    Shutterstock image.

    Get the next $BMY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BMY
    $CVS
    $JNJ
    $KO

    CompanyDatePrice TargetRatingAnalyst
    CVS Health Corporation
    $CVS
    3/12/2026$94.00Mkt Perform → Outperform
    Bernstein
    AT&T Inc.
    $T
    3/11/2026$29.00 → $32.00Outperform
    Oppenheimer
    Verizon Communications Inc.
    $VZ
    3/11/2026$50.00 → $56.00Outperform
    Oppenheimer
    AT&T Inc.
    $T
    3/10/2026$28.00Sell → Neutral
    Arete
    Verizon Communications Inc.
    $VZ
    3/9/2026$54.50Sector Perform → Sector Outperform
    Scotiabank
    Pfizer Inc.
    $PFE
    3/2/2026$35.00Hold → Buy
    Argus
    Realty Income Corporation
    $O
    2/25/2026$61.00 → $70.00Outperform
    RBC Capital Mkts
    Realty Income Corporation
    $O
    2/25/2026$67.75 → $70.50Buy
    Stifel
    More analyst ratings

    $BMY
    $CVS
    $JNJ
    $KO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and President, Aetna Nelson Steven H bought $1,289 worth of shares (24 units at $53.70) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    1/27/26 5:20:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Levchin Max R bought $998,676 worth of shares (14,267 units at $70.00) (SEC Form 4)

    4 - COCA COLA CO (0000021344) (Issuer)

    10/27/25 4:57:57 PM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $BMY
    $CVS
    $JNJ
    $KO
    SEC Filings

    View All

    SEC Form DEF 14A filed by CVS Health Corporation

    DEF 14A - CVS HEALTH Corp (0000064803) (Filer)

    4/3/26 4:05:26 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form DEFA14A filed by CVS Health Corporation

    DEFA14A - CVS HEALTH Corp (0000064803) (Filer)

    4/3/26 4:05:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 424B5 filed by Realty Income Corporation

    424B5 - REALTY INCOME CORP (0000726728) (Filer)

    3/31/26 7:51:44 AM ET
    $O
    Real Estate Investment Trusts
    Real Estate

    $BMY
    $CVS
    $JNJ
    $KO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Millhiser Amity

    4 - COCA COLA CO (0000021344) (Issuer)

    4/3/26 3:43:06 PM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 4 filed by Lagomasino Maria Elena

    4 - COCA COLA CO (0000021344) (Issuer)

    4/3/26 3:29:00 PM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 4 filed by Botin Ana

    4 - COCA COLA CO (0000021344) (Issuer)

    4/3/26 3:23:57 PM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    $BMY
    $CVS
    $JNJ
    $KO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 11, 2024 - FDA Approves New Treatment for Hemophilia A or B

    For Immediate Release: October 11, 2024 Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors (neutralizing antibodies). “Today’s approval of Hympavzi pro

    10/11/24 2:12:15 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $CVS
    $JNJ
    $KO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CVS Health upgraded by Bernstein with a new price target

    Bernstein upgraded CVS Health from Mkt Perform to Outperform and set a new price target of $94.00

    3/12/26 8:38:26 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Oppenheimer reiterated coverage on Verizon with a new price target

    Oppenheimer reiterated coverage of Verizon with a rating of Outperform and set a new price target of $56.00 from $50.00 previously

    3/11/26 7:56:43 AM ET
    $VZ
    Telecommunications Equipment
    Telecommunications

    Oppenheimer reiterated coverage on AT&T with a new price target

    Oppenheimer reiterated coverage of AT&T with a rating of Outperform and set a new price target of $32.00 from $29.00 previously

    3/11/26 7:56:43 AM ET
    $T
    Telecommunications Equipment
    Telecommunications

    $BMY
    $CVS
    $JNJ
    $KO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Omnicare Advances Court-Supervised Process While Continuing to Deliver Enhanced Value to Customers

    Enters into Asset Purchase Agreement with GenieRx WOONSOCKET, R.I., April 1, 2026 /PRNewswire/ -- Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health (NYSE:CVS), today announced it has entered into an asset purchase agreement with GenieRx Holdings LLC ("GenieRx"), a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services. GenieRx will serve as the "stalking horse bidder" in the Company's ongoing court‑supervised sale process.

    4/1/26 3:07:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    The Coca-Cola Company Announces Timing of First Quarter 2026 Earnings Release

    The Coca-Cola Company today announced it will release first quarter 2026 financial results April 28 before the New York Stock Exchange opens. The release will be followed by an investor conference call at 8:30 a.m. ET to discuss the results. The company invites investors to join a webcast at www.cocacolacompany.com/investors. Downloadable files, as well as a transcript, will be available within 24 hours after the call on the company's website. About The Coca-Cola Company The Coca-Cola Company (NYSE:KO) is a total beverage company with products sold in more than 200 countries and territories. Our company's purpose is to refresh the world and make a difference. We sell multiple billion-

    3/31/26 10:00:00 AM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years

    New survey, guided by patient advocacy input, seeks to elevate lived experience and community voice to better understand challenges in multiple myeloma care Bristol Myers Squibb (NYSE:BMY), a global leader in oncology, today announced the evolution of Standing in the Gaap, a long-running program designed to help address persistent gaps in care for people living with multiple myeloma (MM) in medically underserved communities. Building on a decade of sustained commitment, BMS is reinforcing its focus on equitable access to multiple myeloma education, resources, and community-driven solutions by expanding the program to reach more patients and care partners. As a central element of the Sta

    3/31/26 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $CVS
    $JNJ
    $KO
    Leadership Updates

    Live Leadership Updates

    View All

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials

    The Coca-Cola Company Announces Participation in Citi 2026 Global Consumer & Retail Conference

    The Coca-Cola Company announced today that John Murphy, President and Chief Financial Officer, will present at the Citi 2026 Global Consumer & Retail Conference March 9 at 8 a.m. ET. The company invites investors to join a webcast for this event at coca-colacompany.com/investors. Downloadable files, as well as a transcript, will be available within 24 hours after the event on the company's website. About The Coca-Cola Company The Coca-Cola Company (NYSE:KO) is a total beverage company with products sold in more than 200 countries and territories. Our company's purpose is to refresh the world and make a difference. We sell multiple billion-dollar brands across several beverage categori

    2/25/26 10:00:00 AM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    StandardAero Set to Join S&P MidCap 400

    NEW YORK, Jan. 16, 2026 /PRNewswire/ -- StandardAero Inc. (NYSE:SARO) will replace Frontier Communications Parent Inc. (NASD: FYBR) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, January 22. S&P 500 & S&P 100 constituent Verizon Communications Inc. (NYSE:VZ) is acquiring Frontier Communications Parent in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Jan 22, 2026 S&P MidCap 400 Addition StandardAero SARO Industrials Jan 22, 2026 S&P MidCap 400 Deletion Frontier Communicati

    1/16/26 6:26:00 PM ET
    $FYBR
    $SARO
    $SPGI
    Telecommunications Equipment
    Telecommunications
    Aerospace
    Industrials

    $BMY
    $CVS
    $JNJ
    $KO
    Financials

    Live finance-specific insights

    View All

    The Coca-Cola Company Announces Timing of First Quarter 2026 Earnings Release

    The Coca-Cola Company today announced it will release first quarter 2026 financial results April 28 before the New York Stock Exchange opens. The release will be followed by an investor conference call at 8:30 a.m. ET to discuss the results. The company invites investors to join a webcast at www.cocacolacompany.com/investors. Downloadable files, as well as a transcript, will be available within 24 hours after the call on the company's website. About The Coca-Cola Company The Coca-Cola Company (NYSE:KO) is a total beverage company with products sold in more than 200 countries and territories. Our company's purpose is to refresh the world and make a difference. We sell multiple billion-

    3/31/26 10:00:00 AM ET
    $KO
    Beverages (Production/Distribution)
    Consumer Staples

    AT&T Declares Dividends on Common and Preferred Shares

    DALLAS, March 27, 2026 /CNW/ -- The board of directors today declared a quarterly dividend of $0.2775 per share on the company's common shares, payable May 1, 2026.Key Takeaways:The board of directors declared a quarterly dividend of $0.2775 per share on the company's common shares.Dividends on common stock as well as Series A and Series C preferred stock are payable on May 1, 2026.The board of directors of AT&T (NYSE:T) today declared a quarterly dividend of $0.2775 per share on the company's common shares. The board of directors also declared quarterly dividends on the company's 5.000% Perpetual Preferred Stock, Series A and the company's 4.750% Perpetual Preferred Stock, Series C. The Ser

    3/27/26 4:15:00 PM ET
    $T
    Telecommunications Equipment
    Telecommunications

    Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

    Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, May 5, 2026. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's First Quarter 2026 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance of the conference call. You can also listen to the conference

    3/24/26 10:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMY
    $CVS
    $JNJ
    $KO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Realty Income Corporation

    SC 13G/A - REALTY INCOME CORP (0000726728) (Subject)

    10/16/24 10:51:37 AM ET
    $O
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Johnson & Johnson

    SC 13G - JOHNSON & JOHNSON (0000200406) (Filed by)

    4/10/24 5:12:55 PM ET
    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care